RecruitingNCT03880708

China Inherited Ventricular Arrhythmias Registry

China Inherited Ventricular Arrhythmias Registry, a Multicenter, Observational and Prospective Study


Sponsor

China National Center for Cardiovascular Diseases

Enrollment

500 participants

Start Date

Oct 24, 2017

Study Type

OBSERVATIONAL

Conditions

Summary

This is an observational, prospective, multi-center registry, aiming at building a risk stratification for malignant inherited ventricular arrhythmias, including Brugada syndrome(Brs)、Long QT syndrome(LQTS)、Short QT syndrome(SQTS)、Early repolarization syndrome(ERS) and Catecholaminergic polymorphic ventricular tachycardia(CPVT). 500 participants will be recruited from 10 centers in China, with clinical data to be abstracted from medical records, and blood samples to be collected for finding related genes and promising risk indicators. The follow-up should be made every 6 months.


Eligibility

Min Age: 1 HourMax Age: 90 Years

Inclusion Criteria1

  • diagnosed as Brugada syndrome(Brs)、Long QT syndrome(LQTS)、Short QT syndrome(SQTS)、Early repolarization syndrome(ERS) or Catecholaminergic polymorphic ventricular tachycardia(CPVT).

Exclusion Criteria1

  • patients were enrolled by other clinical trials.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

China National Center for Cardiovascular Diseases

Beijing, Beijing Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03880708


Related Trials